S&P 500
(0.16%) 5 477.90 points
Dow Jones
(0.04%) 39 128 points
Nasdaq
(0.49%) 17 805 points
Oil
(0.06%) $80.88
Gas
(-5.04%) $2.62
Gold
(-0.90%) $2 309.80
Silver
(-0.36%) $28.77
Platinum
(2.90%) $1 015.00
USD/EUR
(0.34%) $0.936
USD/NOK
(0.52%) $10.66
USD/GBP
(0.51%) $0.792
USD/RUB
(0.86%) $88.24

Actualizaciones en tiempo real para Gamida Cell Ltd [GMDA]

Bolsa: NASDAQ Sector: Healthcare Industria: Biotechnology
Última actualización5 abr 2024 @ 16:00

-18.25% $ 0.0327

Live Chart Being Loaded With Signals

Commentary (5 abr 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 6.90% compare to its pairs and should correct upwards.

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia...

Stats
Volumen de hoy 19.05M
Volumen promedio 9.38M
Capitalización de mercado 4.34M
EPS $0.130 ( Q1 | 2024-05-23 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0399
(Sector) 42.63
(Industry) 24.32
ATR14 $0 (0.00%)
AADI -5.88%
ABCL 2.20%
ABCM 0.04%
ABEO -3.08%
ABIO -2.77%
ABOS 0.93%
ABSI 4.42%
ABUS -1.31%
ABVX -2.56%
ACAD -0.64%
ACER -17.95%
ACET -8.84%
ACGN 1.29%
ACHL -2.89%
ACHV 2.59%
ACIU -1.00%
ACLX -0.24%
ACRV -4.29%
ACST -3.58%
ACXP 3.23%
ADAG 7.14%
ADAP -3.97%
ADGI 0.87%
ADIL -3.51%
ADMA -1.54%
ADPT 0.59%
ADTX -3.47%
ADVM 1.01%
ADXN -1.60%
AEON -5.61%
AEZS -2.19%
AFMD -2.62%
AGEN -4.44%
AGIO -2.98%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 7.94%
AKRO -2.43%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -0.92%
ALGS -1.09%
ALKS 1.61%
ALLK -10.17%
ALLO -2.50%
ALLR -3.37%
ALNA 3.16%
ALNY 2.09%
ALPN 0.02%
ALPX 0.00%
ALRN -3.00%
ALT -15.59%
ALVR -1.65%
ALXN 0.00%
ALXO -10.50%
ALZN -1.05%
AMRN -4.13%
AMTI -3.13%
ANAB 1.55%
ANEB 7.20%
ANGN 0.00%
ANIX -4.05%
ANL -0.14%
ANNX 1.53%
ANPC -3.15%
APGE 2.08%
APGN 8.48%
APGNW 30.65%
APLM -6.42%
APLS 0.07%
APLT 0.45%
APM 0.21%
APOP 0.38%
APRE -3.13%
APTO 2.55%
APTX 3.17%
APVO 3.35%
ARAV -13.39%
ARCT -6.81%
ARDS -12.13%
ARDX 1.50%
ARGX -1.26%
ARNA 0.00%
ARPO -0.90%
ARQT -3.23%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.76%
ARWR -2.27%
ASLN -2.23%
ASMB -7.14%
ASND -2.31%
ATAI -3.70%
ATHA 10.05%
ATHE 0.08%
ATHX -33.50%
ATNF 0.99%
ATOS 1.94%
ATRA -6.23%
ATXI 1.94%
ATXS -0.33%
AUPH -1.08%
AURA 4.70%
AUTL -3.45%
AVBP -3.03%
AVEO 0.00%
AVIR -1.75%
AVRO -1.41%
AVTE -0.69%
AVTX -4.26%
AVXL -5.68%
AXLA 0.00%
AXSM -2.39%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.77%
BCAB -7.84%
BCDA -1.02%
BCDAW -46.41%
BCEL 0.00%
BCLI -0.18%
BCRX 1.64%
BCTX 12.76%
BCTXW 11.64%
BCYC 0.95%
BDRX -4.42%
BDTX 0.00%
BEAM 2.43%
BFRA -2.91%
BGNE -3.01%
BIOR -5.65%
BIVI 1.72%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.45%
BLTE -1.65%
BLU 0.03%
BLUE -4.28%
BMEA -14.59%
BMRN 0.33%
BNOX 4.44%
BNTC -5.76%
BNTX -2.20%
BOLD -9.71%
BOLT -1.36%
BPMC -2.47%
BPTH -6.67%
BPTS -13.47%
BRNS -0.37%
BRTX -4.72%
BTAI 11.86%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.48%
CADL 1.06%
CALA 0.00%
CALC -8.27%
CALT -1.87%
CAPR -0.22%
CARA -12.44%
CARM 6.09%
CASI -1.24%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.67%
CCCC -1.70%
CCXI 0.00%
CDAK 0.00%
CDIO -4.74%
CDIOW -28.57%
CDMO -1.27%
CDMOP 0.04%
CDT -13.82%
CDTTW -39.60%
CDTX -6.28%
CDXC 9.43%
CDXS 9.66%
CELC -2.79%
CELU -1.00%
CELUW -15.56%
CERC -1.68%
CERE -1.52%
CERO -4.60%
CEROW -20.36%
CFRX -27.95%
CGEM 0.49%
CGEN -3.31%
CGON -2.90%
CGTX -3.41%
CHMA -6.00%
CHRS 5.06%
CINC 0.00%
CING -3.75%
CINGW 34.95%
CKPT -0.96%
CLBS -16.75%
CLDX -0.28%
CLGN -0.60%
CLLS -3.11%
CLNN -2.47%
CLNNW 0.00%
CLRB 7.04%
CLSD -3.20%
CLSN -0.68%
CLVS 0.00%
CMMB -1.96%
CMND 3.23%
CMPI 0.00%
CMPX 0.00%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.55%
CNCE 0.00%
CNSP -35.21%
CNST 0.00%
CNTA 1.12%
CNTB 0.00%
CNTX -9.59%
COCP -2.40%
COEPW 32.45%
COGT -2.64%
CORT 3.98%
COYA -2.60%
CPRX -0.46%
CRBP -1.94%
CRBU -7.95%
CRDF 3.54%
CRGX -2.01%
CRIS -4.34%
CRNX -5.97%
CRSP 1.22%
CRTX 2.63%
CRVO -7.90%
CRVS 0.56%
CSBR -3.50%
CTCX -11.20%
CTIC 0.06%
CTMX 0.00%
CTNM 4.37%
CTXR -7.15%
CUE -4.50%
CVAC -4.94%
CVKD -1.26%
CWBR 2.80%
CYAD -12.96%
CYCC 19.53%
CYCCP 6.99%
CYCN 7.81%
CYT -2.27%
CYTK -2.12%
CYTO 0.91%
DARE -0.30%
DAWN 0.30%
DBTX -0.81%
DBVT -2.08%
DFFN 10.28%
DICE 0.06%
DMAC 30.97%
DNLI -1.74%
DNTH -2.27%
DOMH -1.06%
DRMA -3.31%
DRMAW -1.25%
DRNA 0.00%
DRTS 2.31%
DRTSW -8.92%
DRUG -0.10%
DSGN -2.42%
DTIL 1.04%
DYAI 9.68%
EARS -1.77%
EDIT -3.22%
EDSA 4.14%
EFTR -3.93%
EFTRW -55.56%
EIGR -9.21%
ELAB -2.41%
ELDN 6.72%
ELEV -2.49%
ELOX 6.15%
ELTX -5.29%
ELVN -1.35%
ELYM 10.04%
ENGN -1.23%
ENGNW -22.50%
ENLV -0.72%
ENOB 1.79%
ENSC 6.53%
ENTA -0.33%
ENTO -4.97%
ENTX 1.60%
ENVB 3.10%
EPIX 2.89%
EPRX -2.87%
EPZM 0.00%
EQ -1.14%
EQRX -2.09%
EQRXW 0.00%
ERAS 5.77%
ERNA -1.11%
ERYP 1.30%
ESLA -1.08%
ESLAW 1.62%
ETNB -7.00%
ETON 2.44%
ETTX 0.00%
EVAX 1.42%
EVGN 2.16%
EVLO 0.00%
EWTX 0.52%
EXAI 0.19%
EXEL 0.54%
EYEG -0.67%
EYEN -3.08%
EYPT -0.85%
FATE -12.37%
FBIO 0.59%
FBIOP 0.87%
FBLG -10.20%
FBRX -0.04%
FDMT -4.50%
FENC -2.90%
FGEN -9.83%
FHTX 5.34%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.72%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.89%
FULC 3.18%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -0.45%
GANX -2.31%
GBIO -1.06%
GBT 0.01%
GDTC 2.03%
GERN -1.55%
GHRS -4.10%
GLMD -2.48%
GLPG -1.91%
GLSI 11.18%
GLTO -3.90%
GLUE -2.64%
GLYC -12.60%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -4.87%
GNPX -3.92%
GNTA 3.94%
GOSS -7.00%
GOVX -8.41%
GOVXW 10.89%
GPCR -5.21%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -3.78%
GRTX 2.19%
GTHX 2.27%
GUTS 0.69%
GXGXW 41.67%
GYRE -5.65%
HALO -0.76%
HARP 0.09%
HCWB -7.15%
HEPA -3.64%
HGEN -84.62%
HILS 5.66%
HLVX 0.08%
HOOK 0.00%
HOTH -2.86%
HOWL 0.00%
HRMY 3.32%
HRTX 9.18%
HSTO 0.00%
HUMA 1.42%
HUMAW -6.25%
IBRX -6.88%
ICCC -0.44%
ICPT 0.21%
ICU 18.87%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.43%
IFRX -1.23%
IGMS -2.05%
IKNA -2.38%
IKT 0.00%
IMAB -0.87%
IMCR -4.15%
IMGN 0.02%
IMGO 0.00%
IMMP 5.32%
IMMX -5.17%
IMNM 4.25%
IMNN -1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.50%
IMTX -1.50%
IMTXW 6.00%
IMUX -9.19%
IMV 0.00%
IMVT -4.51%
INAB -1.80%
INBX -3.11%
INCY -2.14%
INDP 8.72%
INFI -52.38%
INKT 0.00%
INM 0.77%
INMB 1.96%
INO 1.56%
INSM -1.05%
INTS -3.14%
INVA 0.87%
INZY 1.14%
IOBT -7.09%
IONS 1.49%
IOVA -4.02%
IPA 0.50%
IPHA 2.54%
IPSC -3.91%
IRON -2.47%
ISEE 0.38%
ITOS 2.87%
ITRM 1.67%
IVA 6.96%
IVVD 0.00%
JAGX 1.31%
JANX -4.03%
JAZZ -0.85%
JNCE 0.00%
JSPR -1.50%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.96%
KALV -2.08%
KDNY 0.22%
KMPH -0.34%
KNSA -2.32%
KNTE -0.38%
KOD -9.49%
KPRX -4.08%
KPTI -8.71%
KRBP -10.00%
KRON 0.74%
KROS -0.22%
KRRO 0.09%
KRTX 0.03%
KRYS 0.82%
KTRA 9.55%
KTTA -0.65%
KTTAW 82.57%
KURA 0.54%
KYMR -4.04%
KYTX -6.07%
KZIA 4.51%
KZR -3.84%
LABP 0.57%
LBPH 1.57%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.15%
LENZ -3.67%
LEXX 0.77%
LEXXW 23.81%
LGND -1.37%
LGNDV 0.00%
LGVN -9.04%
LIAN -8.28%
LIFE 2.70%
LIPO -9.42%
LIXT -9.81%
LIXTW 45.97%
LJPC -0.32%
LMNL 0.12%
LOGC 0.52%
LPCN -3.68%
LPTX -3.30%
LQDA 0.33%
LRMR -0.21%
LSTA -1.16%
LTRN 6.48%
LUMO 0.67%
LVTX -4.64%
LXEO -13.22%
LXRX -1.18%
LYEL -36.03%
LYRA 3.49%
MACK 0.10%
MBIO -11.26%
MBRX -1.43%
MCRB 0.05%
MDGL -1.67%
MDNA -13.16%
MDWD 4.25%
MDXG -1.77%
MEIP 0.00%
MESO -1.48%
MGNX -5.13%
MGTA -7.74%
MGTX 0.00%
MGX 1.88%
MIRM -0.84%
MIRO 0.59%
MIST 3.08%
MITO 0.00%
MLEC -6.54%
MLECW 3.08%
MLND -5.36%
MLTX 1.23%
MLYS -8.87%
MNKD -0.95%
MNMD 2.83%
MNOV 0.70%
MNPR -9.09%
MOLN 0.76%
MOR 0.45%
MORF -3.16%
MREO -0.29%
MRKR 1.50%
MRNA -11.01%
MRNS -7.35%
MRSN -3.81%
MRTX -0.17%
MRUS 0.37%
MRVI 1.02%
MTCR -1.29%
MTEM 6.93%
MTP -18.50%
MURA -4.95%
MYMD 2.16%
NAMS 0.41%
NAMSW 0.64%
NAUT -1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 10.66%
NCNA -1.45%
NERV -0.32%
NEXI 1.47%
NGM -1.28%
NGNE 2.93%
NKGN 9.24%
NKGNW -20.91%
NKTR 1.40%
NKTX -2.61%
NLSP 7.41%
NLSPW 26.67%
NMRA -1.71%
NMTR -42.97%
NOVN -24.84%
NRBO 13.38%
NRIX -1.63%
NRSN 2.60%
NRSNW 0.00%
NRXP -10.41%
NRXPW 18.33%
NRXS 1.20%
NTBL 2.67%
NTEC -12.45%
NTHI 0.00%
NTLA -4.54%
NTRBW -31.07%
NUVL -1.98%
NVAX -6.36%
NVCT -8.45%
NVIV -34.28%
NXTC -5.88%
NYMX -0.05%
OABI 2.37%
OABIW 2.60%
OBIO 0.15%
OBSV 0.00%
OCEA -3.52%
OCGN 8.47%
OCS 0.25%
OCUL 1.07%
OCUP 0.33%
ODT -4.27%
OKYO 1.72%
OLMA -5.71%
OMER -1.80%
OMGA -2.08%
ONCO 9.93%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 2.97%
ONTX -0.47%
ONVO 1.00%
OPNT 0.00%
OPT -3.09%
ORGS 1.65%
ORIC -1.63%
ORMP 14.73%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.69%
OVID 1.80%
OYST 0.00%
PALI -0.43%
PASG 0.00%
PBLA -7.50%
PBM -3.26%
PBYI 6.08%
PCSA -0.97%
PCVX 0.74%
PDSB -3.80%
PEPG 0.89%
PGEN -7.19%
PHAR 1.99%
PHAS 0.00%
PHAT -1.06%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.55%
PHXM -5.20%
PIRS 0.11%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -3.11%
PLUR 10.43%
PMN -5.55%
PMVP -1.19%
PNT 0.16%
PPBT 2.13%
PRAX 6.33%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 1.79%
PRQR -0.60%
PRTA -3.90%
PRTC -2.46%
PRTG 0.09%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.37%
PSTX -4.26%
PTCT -0.37%
PTE -0.82%
PTGX 0.16%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.90%
QLGN -7.17%
QNCX 2.04%
QNRX -1.34%
QSI -28.31%
QSIAW -9.50%
QTTB 4.94%
QURE -1.35%
RAIN -1.63%
RANI 4.01%
RAPT -0.97%
RARE 1.71%
RCKT -10.73%
REGN -0.19%
RENB -2.48%
REPL -1.25%
RETA 0.02%
REUN -0.89%
REVB -7.44%
REVBU 3.46%
REVBW 4.38%
RGLS -4.67%
RGNX -6.57%
RIGL -6.24%
RLAY -7.12%
RLMD 0.00%
RLYB -6.04%
RNA 2.46%
RNAC 2.87%
RNAZ -0.96%
RNXT 0.89%
ROIV -2.40%
ROIVW 4.56%
RPHM -2.48%
RPRX -1.19%
RPTX -1.17%
RUBY 2.70%
RVLP -32.05%
RVMD -1.06%
RVMDW -30.00%
RVNC -0.43%
RVPH -0.79%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.61%
RYTM -6.74%
RYZB 0.02%
RZLT 3.36%
SABS -3.41%
SABSW -5.53%
SAGE -0.55%
SANA -3.14%
SAVA -3.78%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.56%
SCPH 12.12%
SCPS 0.00%
SEEL -2.79%
SEER -1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -5.19%
SGMT -4.83%
SGTX -2.56%
SIOX 22.63%
SLDB -1.72%
SLGL 5.23%
SLN -8.22%
SLNO 1.59%
SLRX 0.40%
SLS -4.27%
SMMT -3.00%
SNDX 1.74%
SNGX 3.02%
SNPX -2.77%
SONN 0.20%
SPPI -0.49%
SPRB -1.64%
SPRC -2.99%
SPRO 0.00%
SRNE 0.00%
SRPT -0.73%
SRRA 0.00%
SRRK -2.85%
SRZN 6.13%
STAB 0.00%
STOK -7.38%
STRO -1.84%
STSA 0.00%
STTK 6.61%
SURF -0.93%
SVRA 1.05%
SWTX -0.49%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -6.90%
TARS -2.13%
TBPH 0.12%
TCBP 8.77%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT -1.21%
TCRX -1.29%
TECH -1.33%
TENX -0.32%
TERN -8.00%
TFFP -12.18%
TGTX -7.61%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.41%
TNGX -4.21%
TNXP -10.00%
TNYA -4.73%
TPST 4.85%
TRDA -4.54%
TRVI 1.53%
TRVN 2.74%
TSHA -17.24%
TSVT -4.26%
TTNP -6.21%
TVTX 3.64%
TYRA -6.95%
UBX -2.13%
UNCY -4.00%
URGN 4.18%
UTHR -0.03%
VACC 11.36%
VALN -3.15%
VAXX 113.13%
VBIV -0.78%
VBLT -8.77%
VCEL 1.94%
VCNX 5.26%
VCYT -1.01%
VERA -4.29%
VERU 0.54%
VERV -4.02%
VIGL 1.61%
VINC 2.81%
VIR -1.30%
VIRI -4.25%
VIRX -1.75%
VKTX -0.86%
VLON -13.04%
VNDA -2.61%
VOR -7.26%
VRCA 0.14%
VRDN -3.53%
VRNA -2.33%
VRPX -0.48%
VRTX 0.04%
VSTM 4.42%
VTGN -2.11%
VTVT -0.18%
VTYX -2.93%
VXRT -2.09%
VYGR -0.26%
VYNE -7.51%
VYNT 7.78%
WINT -2.72%
WVE -8.28%
XBIO 1.03%
XBIT 1.88%
XCUR 1.26%
XENE -1.16%
XERS 4.76%
XFOR 4.17%
XLO 1.33%
XLRN 0.00%
XNCR 0.41%
XOMA -7.75%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.97%
ZNTL -0.95%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-01-31 Moch Kenneth I Buy 200 000 Ordinary Shares
2024-01-31 Wills Stephen T Buy 200 000 Ordinary Shares
2024-01-31 Tomasello Shawn Buy 200 000 Ordinary Shares
2024-01-31 Adams Julian Buy 200 000 Ordinary Shares
2024-01-31 Simantov Ronit Buy 480 319 Ordinary Shares
INSIDER POWER
95.68
Last 90 transactions
Buy: 8 073 627 | Sell: 418 674
Correlación (AI algo v.1.1b): Undervalued: 6.90% $0.0373 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.12 (neutral)
Corto: 0.82 (strong)
Signal:(73.984) Same movement expected

Gamida Cell Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gamida Cell Ltd Correlación - Moneda/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Gamida Cell Ltd Finanzas

Annual 2023
Ingresos: $1.78M
Beneficio Bruto: $-1.69M (-94.96 %)
EPS: $-0.570
FY 2023
Ingresos: $1.78M
Beneficio Bruto: $-1.69M (-94.96 %)
EPS: $-0.570
FY 2022
Ingresos: $0
Beneficio Bruto: $-440 000 (0.00 %)
EPS: $-2.42
FY 2021
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $0

Financial Reports:

No articles found.

Gamida Cell Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Gamida Cell Ltd

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to treat hematologic malignancies and solid tumors. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico

Total Execution Time: 1.7938659191132 seconds
Number of API calls: 3
Number of DB calls: 9